BIOGRAPHICAL SKETCH NAME: ANASTASIA CHATZIDIMITRIOU POSITION TITLE: SENIOR RESEARCHER

Transcription

1 BIOGRAPHICAL SKETCH NAME: ANASTASIA CHATZIDIMITRIOU POSITION TITLE: SENIOR RESEARCHER EDUCATION/TRAINING: BIOLOGY INSTITUTION AND LOCATION Completion Date FIELD OF STUDY ARISTOTLE UNIVERSITY OF THESSALONIKI 11/2004 BIOLOGY UNIVERSITY OF THESSALY 07/2006 IMMUNOBIOLOGY AND HUMAN GENETICS Personal Statement Dr. Anastasia Hadzidimitriou is a Senior Researcher at the Institute of Applied Biosciences. She studied Biology in the Aristotle University of Thessaloniki (AUTH) and holds a PhD in Immunogenetics of chronic lymphocytic leukemia (CLL, 2006). Since September 2006, she is a postdoc in INAB/CERTH in close cooperation with the Molecular Biology Lab of the Department of Hematology and Transplantation Unit of G. Papanicolaou Hospital, Thessaloniki, Greece. Since November 2017 she is a Senior Researcher at the Institute of Applied Biosciences (INAB/CERTH) where she continues her research activities on the field of immunobiology and genetics by NGS methodologies for the detection of new biomarkers. She is responsible for the node of biobanks at INAB part of the European Infrastructure of BBMRI-ERIC (Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium). Since 2016 she is responsible for the management of Real world Evidence and the accreditation of diagnostics tests in The European Research Initiative on Chronic Lymphocytic Leukemia, a working group of the European Hematology Association. Positions and Honors 2017 today: Senior Researcher, Institute of Applied Biosciences (INAB), Centre for Research and Technology Hellas (CERTH) - Main research focus: High-throughput immunogenetics analysis for unique scenarios of clinical value in immunology - Responsible for the Biobank of INAB [a node of the Biobanking and BioMolecular resources Research Infrastructures (BBMRI) a pan-european Research Infrastructure] 2014 today: Junior Researcher, Institute of Applied Biosciences (INAB), Centre for Research and Technology Hellas (CERTH) today: European Research Initiative in Chronic Lymphocytic Leukemia [ ERIC], a working group of the European Hematology Association (EHA) Roles within ERIC: - Coordination of the CLL Database - Coordination of Immunoglobulin analysis accreditation - EU Infrastructures and frameworks 2008 Postdoctoral researcher, Centre National de la Recherche Scientifique [CNRS], Immunogenetics group [ΙMGT], Montpellier, France (Prof. Μ-P Lefranc) today: Member of the Greek Hematology Association

2 today: Member of the European Hematolofy Asociation (EHA) today: Member of the Immunoglobulin gene analysis in CLL working group [IgCLL] today: Member of the IMGT/CLL-DB group [ today: Member of the European Initiative in Chronic Lymphocytic Leukemia [ ERIC], a working group of the European Hematology Association (EHA) [ today: Euroclonality NGS Consotium [ Teaching Experience Lecturer PD407/80 Department of Molecular Bilogy and Genetics, Dimokritio University of Thrace. Molecular Biology, Human Genetics, Genetics I & II Foreign Languages - English Certificate of Proficiency in English University of Cambridge. - Italian Diploma di lingua italiana, Instituto Italiano di Cultura, Salonicco. - German Zertifikat Deutsch als Fremdsprache, Goethe Institut. - French Delf - Niveau B2 Contributions to Science i. Metrics - 43 peer-reviewed publications (Pubmed, 14 January 2018) 27 reviews, 165 original articles - h-factor: 16; total citations: 1454 (self-citations excluded) (Scopus, 14 January December 2018) ii. Peer-reviewed publications 1: BALIAKAS P, MATTSSON M, HADZIDIMITRIOU A, MINGA E, AGATHANGELIDIS A, SUTTON LA, SCARFO L, DAVIS Z, YAN XJ, PLEVOVA K, SANDBERG Y, VOJDEMAN FJ, TZENOU T, CHU CC, VERONESE S, MANSOURI L, SMEDBY KE, GIUDICELLI V, NGUYEN-KHAC F, PANAGIOTIDIS P, JULIUSSON G, ANAGNOSTOPOULOS A, LEFRANC MP, TRENTIN L, CATHERWOOD M, MONTILLO M, NIEMANN CU, LANGERAK AW, POSPISILOVA S, STAVROYIANNI N, CHIORAZZI N, OSCIER D, JELINEK DF, SHANAFELT T, DARZENTAS N, BELESSI C, DAVI F, GHIA P, ROSENQUIST R, STAMATOPOULOS K. NO IMPROVEMENT IN LONG-TERM SURVIVAL OVER TIME FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS IN STEREOTYPED SUBSETS #1 AND #2 TREATED WITH CHEMO(IMMUNO)THERAPY. HAEMATOLOGICA DEC 21. PII: HAEMATOL DOI: /HAEMATOL : VARDI A, STAMATOPOULOS K, HADZIDIMITRIOU A. T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA: CAN THEY FIGHT? ONCOTARGET NOV 3;8(59): : SUTTON LA, HADZIDIMITRIOU A, BALIAKAS P, AGATHANGELIDIS A, LANGERAK AW, STILGENBAUER S, POSPISILOVA S, DAVIS Z, FORCONI F, DAVI F, GHIA P, ROSENQUIST R, STAMATOPOULOS K; EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC). IMMUNOGLOBULIN GENESIN CHRONIC LYMPHOCYTIC LEUKEMIA: KEY TO UNDERSTANDING THE DISEASE AND IMPROVING RISK STRATIFICATION. HAEMATOLOGICA JUN;102(6): : XOCHELLI A, BALIAKAS P, KAVAKIOTIS I, AGATHANGELIDIS A, SUTTON LA, MINGA E, NTOUFA S, TAUSCH E, YAN XJ, SHANAFELT T, PLEVOVA K, BOUDJOGRA M, ROSSI D, DAVIS Z, NAVARRO A, SANDBERG Y, VOJDEMAN FJ, SCARFO L, STAVROYIANNI N, SUDARIKOV A, VERONESE S, TZENOU T, KARAN- DJURASEVIC T, CATHERWOOD M, KIENLE D, CHATZOULI M, FACCO M, BAHLO J, POTT C, PEDERSEN LB, MANSOURI L, SMEDBY KE, CHU CC, GIUDICELLI V, LEFRANC MP, PANAGIOTIDIS P, JULIUSSON G, ANAGNOSTOPOULOS A, VLAHAVAS I, ANTIC D, TRENTIN L, MONTILLO M, NIEMANN C, DÖHNER H, LANGERAK AW, POSPISILOVA S, HALLEK M, CAMPO E, CHIORAZZI N, MAGLAVERAS N, OSCIER D, GAIDANO G, JELINEK DF, STILGENBAUER S, CHOUVARDA I, DARZENTAS N, BELESSI C, DAVI F, HADZIDIMITRIOU A, ROSENQUIST R, GHIA P, STAMATOPOULOS K. CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED IGHV4-34 RECEPTORS: SHARED AND DISTINCT IMMUNOGENETIC FEATURES AND CLINICAL OUTCOMES. CLIN CANCER RES MAY 23. DOI: / CCR : MASTRODEMOU S, STALIKA E, VARDI A, GEMENETZI K, SPANOUDAKIS M, KARYPIDOU M, MAVROUDI I, HADZIDIMITRIOU A, STAVROPOULOS-GIOKAS C, PAPADAKI HA, STAMATOPOULOS K. CYTOTOXIC T CELLS IN CHRONIC IDIOPATHIC NEUTROPENIA EXPRESS RESTRICTED ANTIGEN RECEPTORS. LEUK LYMPHOMA DEC;58(12): : POULIOU E, XOCHELLI A, KANELLIS G, STALIKA E, SUTTON LA, NAVARRO A, AGATHANGELIDIS A, DIMOSTHENOUS K, ANAGNOSTOPOULOS A, PATSOURIS E, KORKOLOPOULOU P, SUNDSTROM C, GHIA P, PONZONI M, SANDER B, CAMPO E, ROSENQUIST R, HADZIDIMITRIOU A, STAMATOPOULOS K, PAPADAKI T. NUMEROUS ONTOGENETIC ROADS TO MANTLE CELL LYMPHOMA: IMMUNOGENETIC AND IMMUNOHISTOCHEMICAL EVIDENCE. AM J PATHOL JUL;187(7): : ROSENQUIST R, GHIA P, HADZIDIMITRIOU A, SUTTON LA, AGATHANGELIDIS A, BALIAKAS P, DARZENTAS N, GIUDICELLI V, LEFRANC MP, LANGERAK AW,

3 BELESSI C, DAVI F, STAMATOPOULOS K. IMMUNOGLOBULIN GENE SEQUENCE ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA: UPDATED ERIC RECOMMENDATIONS. LEUKEMIA JUL;31(7): : VARDI A, VLACHONIKOLA E, KARYPIDOU M, STALIKA E, BIKOS V, GEMENETZI K, MARAMIS C, SIORENTA A, ANAGNOSTOPOULOS A, POSPISILOVA S, MAGLAVERAS N, CHOUVARDA I, STAMATOPOULOS K, HADZIDIMITRIOU A. RESTRICTIONS IN THE T-CELL REPERTOIRE OF CHRONIC LYMPHOCYTIC LEUKEMIA: HIGH-THROUGHPUT IMMUNOPROFILING SUPPORTS SELECTION BY SHARED ANTIGENIC ELEMENTS. LEUKEMIA JUL;31(7): : GEMENETZI K, GALIGALIDOU C, VLACHONIKOLA E, STALIKA E, XOCHELLI A, BALIAKAS P, KARYPIDOU M, TOULOUMENIDOU T, MINGA E, DOUKA V, ISKAS M, ATHANASIADOU A, MAKRIS A, STAVROYIANNI N, ANAGNOSTOPOULOS A, HADZIDIMITRIOU A, STAMATOPOULOS K. TP53 GENE P72R POLYMORPHISM IN CHRONIC LYMPHOCYTIC LEUKEMIA: INCIDENCE AND CLINICAL SIGNIFICANCE AMONGST CASES WITH UNMUTATED IMMUNOGLOBULIN RECEPTORS. LEUK LYMPHOMA MAR;58(3): : KAVAKIOTIS I, XOCHELLI A, AGATHANGELIDIS A, TSOUMAKAS G, MAGLAVERAS N, STAMATOPOULOS K, HADZIDIMITRIOU A, VLAHAVAS I, CHOUVARDA I. INTEGRATING MULTIPLE IMMUNOGENETIC DATA SOURCES FOR FEATURE EXTRACTION AND MINING SOMATIC HYPERMUTATION PATTERNS: THE CASE OF "TOWARDS ANALYSIS" IN CHRONIC LYMPHOCYTIC LEUKAEMIA. BMC BIOINFORMATICS JUN 6;17 SUPPL 5: : SUTTON LA, YOUNG E, BALIAKAS P, HADZIDIMITRIOU A, MOYSIADIS T, PLEVOVA K, ROSSI D, KMINKOVA J, STALIKA E, PEDERSEN LB, MALCIKOVA J, AGATHANGELIDIS A, DAVIS Z, MANSOURI L, SCARFÒ L, BOUDJOGHRA M, NAVARRO A, MUGGEN AF, YAN XJ, NGUYEN-KHAC F, LARRAYOZ M, PANAGIOTIDIS P, CHIORAZZI N, NIEMANN CU, BELESSI C, CAMPO E, STREFFORD JC, LANGERAK AW, OSCIER D, GAIDANO G, POSPISILOVA S, DAVI F, GHIA P, STAMATOPOULOS K, ROSENQUIST R; ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL. DIFFERENT SPECTRA OF RECURRENT GENE MUTATIONS IN SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA HARBORING STEREOTYPED B-CELL RECEPTORS. HAEMATOLOGICA AUG;101(8): : BALIAKAS P, PUIGGROS A, XOCHELLI A, SUTTON LA, NGUYEN-KHAC F, GARDINER A, PLEVOVA K, MINGA E, HADZIDIMITRIOU A, WALEWSKA R, MCCARTHY H, ORTEGA M, COLLADO R, GONZÁLEZ T, GRANADA I, LUÑO E, KOTAŠKOVÁ J, MOYSIADIS T, DAVIS Z, STAVROYIANNI N, ANAGNOSTOPOULOS A, STREFFORD JC, POSPISILOVA S, DAVI F, ATHANASIADOU A, ROSENQUIST R, OSCIER D, ESPINET B, STAMATOPOULOS K. ADDITIONAL TRISOMIES AMONGST PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA CARRYING TRISOMY 12: THE ACCOMPANYING CHROMOSOME MAKES A DIFFERENCE. HAEMATOLOGICA JUL;101(7):E : BIKOS V, KARYPIDOU M, STALIKA E, BALIAKAS P, XOCHELLI A, SUTTON LA, PAPADOPOULOS G, AGATHANGELIDIS A, PAPADOPOULOU E, DAVIS Z, ALGARA P, KANELLIS G, TRAVERSE-GLEHEN A, MOLLEJO M, ANAGNOSTOPOULOS A, PONZONI M, GONZALEZ D, POSPISILOVA S, MATUTES E, PIRIS MA, PAPADAKI T, GHIA P, ROSENQUIST R, OSCIER D, DARZENTAS N, TZOVARAS D, BELESSI C, HADZIDIMITRIOU A, STAMATOPOULOS K. AN IMMUNOGENETIC SIGNATURE OF ONGOING ANTIGEN INTERACTIONS IN SPLENIC MARGINAL ZONE LYMPHOMA EXPRESSING IGHV1-2*04 RECEPTORS. CLIN CANCER RES APR15;22(8): : VARDI A, AGATHANGELIDIS A, STALIKA E, KARYPIDOU M, SIORENTA A, ANAGNOSTOPOULOS A, ROSENQUIST R, HADZIDIMITRIOU A, GHIA P, SUTTON LA, STAMATOPOULOS K. ANTIGEN SELECTION SHAPES THE T-CELL REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA. CLIN CANCER RES JAN 1;22(1): : BALIAKAS P, HADZIDIMITRIOU A, AGATHANGELIDIS A, ROSSI D, SUTTON LA, KMINKOVA J, SCARFO L, POSPISILOVA S, GAIDANO G, STAMATOPOULOS K, GHIA P, ROSENQUIST R. PROGNOSTIC RELEVANCE OF MYD88 MUTATIONS IN CLL: THE JURY IS STILL OUT. BLOOD AUG 20;126(8): : BYSTRY V, AGATHANGELIDIS A, BIKOS V, SUTTON LA, BALIAKAS P, HADZIDIMITRIOU A, STAMATOPOULOS K, DARZENTAS N; EUROPEAN RESEARCH INITIATIVE ON CLL. ARREST/ASSIGNSUBSETS: A NOVEL APPLICATION FOR ROBUST SUBCLASSIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA BASED ON B CELL RECEPTOR IG STEREOTYPY. BIOINFORMATICS DEC 1;31(23): : XOCHELLI A, SUTTON LA, AGATHANGELIDIS A, STALIKA E, KARYPIDOU M, MARANTIDOU F, LOPEZ AN, PAPADOPOULOS G, SUPIKOVA J, GROENEN P, BOUDJOGRA M, SUNDSTROM C, PONZONI M, FRANCOVA HS, ANAGNOSTOPOULOS A, POSPISILOVA S, PAPADAKI T, TZOVARAS D, GHIA P, POTT C, DAVI F, CAMPO E, ROSENQUIST R, HADZIDIMITRIOU A, BELESSI C, STAMATOPOULOS K. MOLECULAR EVIDENCE FOR ANTIGEN DRIVE IN THE NATURAL HISTORY OF MANTLE CELL LYMPHOMA. AM J PATHOL JUN;185(6): : BALIAKAS P, AGATHANGELIDIS A, HADZIDIMITRIOU A, SUTTON LA, MINGA E, TSANOUSA A, SCARFÒ L, DAVIS Z, YAN XJ, SHANAFELT T, PLEVOVA K, SANDBERG Y, VOJDEMAN FJ, BOUDJOGRA M, TZENOU T, CHATZOULI M, CHU CC, VERONESE S, GARDINER A, MANSOURI L, SMEDBY KE, PEDERSEN LB, MORENO D, VAN LOM K, GIUDICELLI V, FRANCOVA HS, NGUYEN-KHAC F, PANAGIOTIDIS P, JULIUSSON G, ANGELIS L, ANAGNOSTOPOULOS A, LEFRANC MP, FACCO M, TRENTIN L, CATHERWOOD M, MONTILLO M, GEISLER CH, LANGERAK AW, POSPISILOVA S, CHIORAZZI N, OSCIER D, JELINEK DF, DARZENTAS N, BELESSI C, DAVI F, GHIA P, ROSENQUIST R, STAMATOPOULOS K. NOT ALL IGHV3-21 CHRONIC LYMPHOCYTIC LEUKEMIAS ARE EQUAL: PROGNOSTIC CONSIDERATIONS. BLOOD JAN 29;125(5): : SUTTON LA, PAPADOPOULOS G, HADZIDIMITRIOU A, PAPADOPOULOS S, KOSTARELI E, ROSENQUIST R, TZOVARAS D, STAMATOPOULOS K. AN ENTITY EVOLVING INTO A COMMUNITY: DEFINING THE COMMON ANCESTOR AND EVOLUTIONARY TRAJECTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA STEREOTYPED SUBSET #4. MOL MED APR 2;20: : XOCHELLI A, AGATHANGELIDIS A, KAVAKIOTIS I, MINGA E, SUTTON LA, BALIAKAS P, CHOUVARDA I, GIUDICELLI V, VLAHAVAS I, MAGLAVERAS N, BONELLO L, TRENTIN L, TEDESCHI A, PANAGIOTIDIS P, GEISLER C, LANGERAK AW, POSPISILOVA S, JELINEK DF, OSCIER D, CHIORAZZI N, DARZENTAS N, DAVI F, GHIA P, ROSENQUIST R, HADZIDIMITRIOU A, BELESSI C, LEFRANC MP, STAMATOPOULOS K. IMMUNOGLOBULIN HEAVY VARIABLE (IGHV) GENES AND ALLELES: NEW ENTITIES, NEW NAMES AND IMPLICATIONS FOR RESEARCH AND PROGNOSTICATION IN CHRONIC LYMPHOCYTIC LEUKAEMIA. IMMUNOGENETICS JAN;67(1):61-6.

4 21: BALIAKAS P, HADZIDIMITRIOU A, SUTTON LA, MINGA E, AGATHANGELIDIS A, NICHELATTI M, TSANOUSA A, SCARFÒ L, DAVIS Z, YAN XJ, SHANAFELT T, PLEVOVA K, SANDBERG Y, VOJDEMAN FJ, BOUDJOGRA M, TZENOU T, CHATZOULI M, CHU CC, VERONESE S, GARDINER A, MANSOURI L, SMEDBY KE, PEDERSEN LB, VAN LOM K, GIUDICELLI V, FRANCOVA HS, NGUYEN-KHAC F, PANAGIOTIDIS P, JULIUSSON G, ANGELIS L, ANAGNOSTOPOULOS A, LEFRANC MP, FACCO M, TRENTIN L, CATHERWOOD M, MONTILLO M, GEISLER CH, LANGERAK AW, POSPISILOVA S, CHIORAZZI N, OSCIER D, JELINEK DF, DARZENTAS N, BELESSI C, DAVI F, ROSENQUIST R, GHIA P, STAMATOPOULOS K. CLINICAL EFFECT OF STEREOTYPED B-CELL RECEPTOR IMMUNOGLOBULINS IN CHRONIC LYMPHOCYTIC LEUKAEMIA: A RETROSPECTIVE MULTICENTRE STUDY. LANCET HAEMATOL NOV;1(2):E : BALIAKAS P, HADZIDIMITRIOU A, SUTTON LA, ROSSI D, MINGA E, VILLAMOR N, LARRAYOZ M, KMINKOVA J, AGATHANGELIDIS A, DAVIS Z, TAUSCH E, STALIKA E, KANTOROVA B, MANSOURI L, SCARFÒ L, CORTESE D, NAVRKALOVA V, ROSE-ZERILLI MJ, SMEDBY KE, JULIUSSON G, ANAGNOSTOPOULOS A, MAKRIS AM, NAVARRO A, DELGADO J, OSCIER D, BELESSI C, STILGENBAUER S, GHIA P, POSPISILOVA S, GAIDANO G, CAMPO E, STREFFORD JC, STAMATOPOULOS K, ROSENQUIST R; EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC). RECURRENT MUTATIONS REFINE PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA. LEUKEMIA FEB;29(2): : COLOMBO M, CUTRONA G, REVERBERI D, BRUNO S, GHIOTTO F, TENCA C, STAMATOPOULOS K, HADZIDIMITRIOU A, CECCARELLI J, SALVI S, BOCCARDO S, CALEVO MG, DE SANTANNA A, TRUINI M, FAIS F, FERRARINI M. EXPRESSION OF IMMUNOGLOBULIN RECEPTORS WITH DISTINCTIVE FEATURES INDICATING ANTIGEN SELECTION BY MARGINAL ZONE B CELLS FROM HUMAN SPLEEN. MOL MED SEP 17;19: : NAVARRO A, CLOT G, ROYO C, JARES P, HADZIDIMITRIOU A, AGATHANGELIDIS A, BIKOS V, DARZENTAS N, PAPADAKI T, SALAVERRIA I, PINYOL M, PUIG X, PALOMERO J, VEGLIANTE MC, AMADOR V, MARTINEZ-TRILLOS A, STEFANCIKOVA L, WIESTNER A, WILSON W, POTT C, CALASANZ MJ, TRIM N, ERBER W, SANDER B, OTT G, ROSENWALD A, COLOMER D, GINÉ E, SIEBERT R, LOPEZ-GUILLERMO A, STAMATOPOULOS K, BEÀ S, CAMPO E. MOLECULAR SUBSETS OF MANTLE CELL LYMPHOMA DEFINED BY THE IGHV MUTATIONAL STATUS AND SOX11 EXPRESSION HAVE DISTINCT BIOLOGIC AND CLINICAL FEATURES. CANCER RES OCT 15;72(20): : AGATHANGELIDIS A, DARZENTAS N, HADZIDIMITRIOU A, BROCHET X, MURRAY F, YAN XJ, DAVIS Z, VAN GASTEL-MOL EJ, TRESOLDI C, CHU CC, CAHILL N, GIUDICELLI V, TICHY B, PEDERSEN LB, FORONI L, BONELLO L, JANUS A, SMEDBY K, ANAGNOSTOPOULOS A, MERLE-BERAL H, LAOUTARIS N, JULIUSSON G, DI CELLE PF, POSPISILOVA S, JURLANDER J, GEISLER C, TSAFTARIS A, LEFRANC MP, LANGERAK AW, OSCIER DG, CHIORAZZI N, BELESSI C, DAVI F, ROSENQUIST R, GHIA P, STAMATOPOULOS K. STEREOTYPED B-CELL RECEPTORS IN ONE-THIRD OF CHRONIC LYMPHOCYTIC LEUKEMIA: A MOLECULAR CLASSIFICATION WITH IMPLICATIONS FOR TARGETED THERAPIES. BLOOD MAY 10;119(19): : BIKOS V, DARZENTAS N, HADZIDIMITRIOU A, DAVIS Z, HOCKLEY S, TRAVERSE-GLEHEN A, ALGARA P, SANTORO A, GONZALEZ D, MOLLEJO M, DAGKLIS A, GANGEMI F, BOSLER DS, BOURIKAS G, ANAGNOSTOPOULOS A, TSAFTARIS A, IANNITTO E, PONZONI M, FELMAN P, BERGER F, BELESSI C, GHIA P, PAPADAKI T, DOGAN A, DEGANO M, MATUTES E, PIRIS MA, OSCIER D, STAMATOPOULOS K. OVER 30% OF PATIENTS WITH SPLENIC MARGINAL ZONE LYMPHOMA EXPRESS THE SAME IMMUNOGLOBULIN HEAVY VARIABLE GENE: ONTOGENETIC IMPLICATIONS. LEUKEMIA JUL;26(7): : AGATHANGELIDIS A, HADZIDIMITRIOU A, ROSENQUIST R, STAMATOPOULOS K. UNLOCKING THE SECRETS OF IMMUNOGLOBULIN RECEPTORS IN MANTLE CELL LYMPHOMA: IMPLICATIONS FOR THE ORIGIN AND SELECTION OF THE MALIGNANT CELLS. SEMIN CANCER BIOL NOV;21(5): : HADZIDIMITRIOU A, AGATHANGELIDIS A, DARZENTAS N, MURRAY F, DELFAU-LARUE MH, PEDERSEN LB, LOPEZ AN, DAGKLIS A, ROMBOUT P, BELDJORD K, KOLSTAD A, DREYLING MH, ANAGNOSTOPOULOS A, TSAFTARIS A, MAVRAGANI-TSIPIDOU P, ROSENWALD A, PONZONI M, GROENEN P, GHIA P, SANDER B, PAPADAKI T, CAMPO E, GEISLER C, ROSENQUIST R, DAVI F, POTT C, STAMATOPOULOS K. IS THERE A ROLE FOR ANTIGEN SELECTION IN MANTLE CELL LYMPHOMA? IMMUNOGENETIC SUPPORT FROM A SERIES OF 807 CASES. BLOOD SEP 15;118(11): : LANGERAK AW, DAVI F, GHIA P, HADZIDIMITRIOU A, MURRAY F, POTTER KN, ROSENQUIST R, STAMATOPOULOS K, BELESSI C; EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC). IMMUNOGLOBULIN SEQUENCE ANALYSIS AND PROGNOSTICATION IN CLL: GUIDELINES FROM THE ERIC REVIEW BOARD FOR RELIABLE INTERPRETATION OF PROBLEMATIC CASES. LEUKEMIA JUN;25(6): : HADZIDIMITRIOU A, DARZENTAS N, KARAKOLI A, KOLIOUSKAS D, TSAFTARIS A, ANAGNOSTOPOULOS A, STAMATOPOULOS K. COEXISTENCE OF DIFFERENT TYPES OF BIALLELIC IMMUNOGLOBULIN HEAVY VARIABLE GENE REPLACEMENT EVENTS IN A CASE OF PEDIATRIC B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. LEUK LYMPHOMA SEP;51(9): : KOSTARELI E, SUTTON LA, HADZIDIMITRIOU A, DARZENTAS N, KOUVATSI A, TSAFTARIS A, ANAGNOSTOPOULOS A, ROSENQUIST R, STAMATOPOULOS K. INTRACLONAL DIVERSIFICATION OF IMMUNOGLOBULIN LIGHT CHAINS IN A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA ALLUDES TO ANTIGEN-DRIVEN CLONAL EVOLUTION. LEUKEMIA JUL;24(7): : DARZENTAS N, HADZIDIMITRIOU A, MURRAY F, HATZI K, JOSEFSSON P, LAOUTARIS N, MORENO C, ANAGNOSTOPOULOS A, JURLANDER J, TSAFTARIS A, CHIORAZZI N, BELESSI C, GHIA P, ROSENQUIST R, DAVI F, STAMATOPOULOS K. A DIFFERENT ONTOGENESIS FOR CHRONIC LYMPHOCYTIC LEUKEMIA CASES CARRYING STEREOTYPED ANTIGEN RECEPTORS: MOLECULAR AND COMPUTATIONAL EVIDENCE. LEUKEMIA JAN;24(1): : SUTTON LA, KOSTARELI E, HADZIDIMITRIOU A, DARZENTAS N, TSAFTARIS A, ANAGNOSTOPOULOS A, ROSENQUIST R, STAMATOPOULOS K. EXTENSIVE INTRACLONAL DIVERSIFICATION IN A SUBGROUP OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH STEREOTYPED IGHV4-34 RECEPTORS: IMPLICATIONS FOR ONGOING INTERACTIONS WITH ANTIGEN. BLOOD NOV 12;114(20): : KOSTARELI E, HADZIDIMITRIOU A, STAVROYIANNI N, DARZENTAS N, ATHANASIADOU A, GOUNARI M, BIKOS V, AGATHAGELIDIS A, TOULOUMENIDOU T, ZORBAS I, KOUVATSI A, LAOUTARIS N, FASSAS A, ANAGNOSTOPOULOS A, BELESSI C, STAMATOPOULOS K. MOLECULAR EVIDENCE FOR EBV AND CMV PERSISTENCE IN A SUBSET OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA EXPRESSING STEREOTYPED IGHV4-34 B-CELL RECEPTORS. LEUKEMIA MAY;23(5): : HADZIDIMITRIOU A, DARZENTAS N, MURRAY F, SMILEVSKA T, ARVANITI E, TRESOLDI C, TSAFTARIS A, LAOUTARIS N, ANAGNOSTOPOULOS A, DAVI F, GHIA P, ROSENQUIST R, STAMATOPOULOS K, BELESSI C. EVIDENCE FOR THE SIGNIFICANT ROLE OF IMMUNOGLOBULIN LIGHT CHAINS IN ANTIGEN RECOGNITION AND SELECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA. BLOOD JAN 8;113(2):

5 36: SMILEVSKA T, TSAKOU E, HADZIDIMITRIOU A, BIKOS V, STAVROYIANNI N, LAOUTARIS N, FASSAS A, ALPHANAGNOSTOPOULOS A, PAPADAKI T, BELESSI C, STAMATOPOULOS K. IMMUNOGLOBULIN KAPPA GENE REPERTOIRE AND SOMATIC HYPERMUTATION PATTERNS IN FOLLICULAR LYMPHOMA. BLOOD CELLS MOL DIS SEP-OCT;41(2): : MURRAY F, DARZENTAS N, HADZIDIMITRIOU A, TOBIN G, BOUDJOGRA M, SCIELZO C, LAOUTARIS N, KARLSSON K, BARAN-MARZSAK F, TSAFTARIS A, MORENO C, ANAGNOSTOPOULOS A, CALIGARIS-CAPPIO F, VAUR D, OUZOUNIS C, BELESSI C, GHIA P, DAVI F, ROSENQUIST R, STAMATOPOULOS K. STEREOTYPED PATTERNS OF SOMATIC HYPERMUTATION IN SUBSETS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: IMPLICATIONS FOR THE ROLE OF ANTIGEN SELECTION IN LEUKEMOGENESIS. BLOOD FEB 1;111(3): : STAMATOPOULOS K, BELESSI C, MORENO C, BOUDJOGRAH M, GUIDA G, SMILEVSKA T, BELHOUL L, STELLA S, STAVROYIANNI N, CRESPO M, HADZIDIMITRIOU A, SUTTON L, BOSCH F, LAOUTARIS N, ANAGNOSTOPOULOS A, MONTSERRAT E, FASSAS A, DIGHIERO G, CALIGARIS-CAPPIO F, MERLE-BÉRAL H, GHIA P, DAVI F. OVER 20% OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA CARRY STEREOTYPED RECEPTORS: PATHOGENETIC IMPLICATIONS AND CLINICAL CORRELATIONS. BLOOD JAN 1;109(1): : HADZIDIMITRIOU A, STAMATOPOULOS K, BELESSI C, LALAYIANNI C, STAVROYIANNI N, SMILEVSKA T, HATZI K, LAOUTARIS N, ANAGNOSTOPOULOS A, KOLLIA P, FASSAS A. IMMUNOGLOBULIN GENES IN MULTIPLE MYELOMA: EXPRESSED AND NON-EXPRESSED REPERTOIRES, HEAVY AND LIGHT CHAIN PAIRINGS AND SOMATIC MUTATION PATTERNS IN A SERIES OF 101 CASES. HAEMATOLOGICA JUN;91(6): : BELESSI C, STAMATOPOULOS K, HADZIDIMITRIOU A, HATZI K, SMILEVSKA T, STAVROYIANNI N, MARANTIDOU F, PATERAKIS G, FASSAS A, ANAGNOSTOPOULOS A, LAOUTARIS N. ANALYSIS OF EXPRESSED AND NON-EXPRESSED IGK LOCUS REARRANGEMENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA. MOL MED JAN-DEC;11(1-12): : STAMATOPOULOS K, BELESSI C, HADZIDIMITRIOU A, SMILEVSKA T, KALAGIAKOU E, HATZI K, STAVROYIANNI N, ATHANASIADOU A, TSOMPANAKOU A, PAPADAKI T, KOKKINI G, PATERAKIS G, SALOUM R, LAOUTARIS N, ANAGNOSTOPOULOS A, FASSAS A. IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA. BLOOD NOV 15;106(10): : SMILEVSKA T, STAMATOPOULOS K, SAMARA M, BELESSI C, TSOMPANAKOU A, PATERAKIS G, STAVROYIANNI N, ATHANASIADOU I, CHIOTOGLOU I, HADZIDIMITRIOU A, ATHANASIADOU A, DOUKA V, SALOUM R, LAOUTARIS N, ANAGNOSTOPOULOS A, FASSAS A, STATHAKIS N, KOLLIA P. TRANSFERRIN RECEPTOR-1 AND 2 EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA. LEUK RES FEB;30(2): : STAMATOPOULOS K, BELESSI C, PAPADAKI T, STAVROYIANNI N, HADZIDIMITRIOU A, KOSMAS C, LAOUTARIS N, FASSAS A, ANAGNOSTOPOULOS A. SOMATIC HYPERMUTATION PATTERNS IN GERMINAL CENTER B CELL MALIGNANCIES. HEMATOLOGY OCT;8(5): REVIEW.